Morphological features correlation with serum tumour markers in prostatic carcinoma

Journal of the College of Physicians and Surgeons Pakistan

Volumn 13, Issue 9, 2003, Pages 511-514

  Afzal, Saeed ^a   Ahmad, Mumtaz ^a   Mushtaq, Sajid ^b   Mubarik, Azhar ^a   Qureshi, Ayaz Hussain ^a   Khan, Saleem Ahmad ^a  

^a ARMY MEDICAL COLLEGE   (Pakistan)

^b Combined Military Hospital ^*  (Pakistan)

Author keywords

Gleason grade and score; Prostate specific antigen (PSA); Prostatic acid phosphatase (PAP); Prostatic carcinoma; Transurethral resection of prostate (T.U.R.P)

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; EOSIN; HEMATOXYLIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MORPHOLOGY; PAKISTAN; PREOPERATIVE PERIOD; PROSTATE BIOPSY; PROSTATE CARCINOMA; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0142010980     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Boring CC. Cancer statistics. CA Cancer J Clin 1994; 44: 7.
2. Ahmad M, Khan AH, Mansoor A. The pattern of malignant tumours in northen Pakistan. J Pak Med Assoc 1991; 41: 270-3.
3. Bhurgi Y. Epidemiology of cancer in Karachi: survey report, J Pak Med Assoc 2001: 49-73.
4. Male reproductive system. In: Rosai J, (edi). Ackerman's surgical pathology. 8th ed. St. Louis: Mosby 1996: 1229-46.
5. Mostofi FK. Pathology of carcinoma of the prostate cancer. 1992; 70: 253.
6. Gleason DF. Histologic grading of prostate cancer: a perspective. Human Pathol 1992; 23: 273-9.
7. Manji M. Prostate specific antigen: an overview. Ann Saudi Med 2002; 22: 1-3.
8. Barry MJ. Prostate - specific antigen : testing for early diagnosis of prostate cancer. N Engl J Med 2001 ; 344: 1373.
9. Rana A, Karamanis K, Lucas MG, Chisholm GD. Identification of metastatic disease by T-category, Gleason score and serum PSA levels in patients with carcinoma of the prostate. Br J Urol 1992; 69: 277-81.
10. Arcangeli CG. Prostate specific-antigen as a screening test for prostate cancer: the United States experience. Urol Clin North Am 1997; 24: 299.
11. Brawer MK, Lange PH. Prostate-specific antigen in the management of prostatic carcinoma. Urol 1989; 33 :11-6.
12. Stamey TA, Yang N, Hay AR, McNeil JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-16.
13. Vashi AR, Oesterling JE. Percent-free prostate-specific antigen: entering a new era in the detection of prostate cancer. Myo Clin Proc 1997; 72: 337.
14. Minardi D, Galosi AB, Recchioni A, Polito M, Mozzorigro G. Diagnostic accuracy of percent-free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients. Urol Int 2001; 67: 272-82.
15. Osterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Effect of cystoscopy, prostate biopsy and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 1993; 42: 276-82.
16. Nadler RB, Humphrey PA, Smith DS. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate-specific antigen levels. J Urol 1995; 154: 407-13.
17. The male genital system. In: Cotron RS, Kumar V, Collins T, (edi). Robbins pathologic basis of disease. 7th ed. Philadelphia : WB Saunders 2003:667-9.
18. Mehdi I. Metastatic prostate cancer. J Pak Med Assoc 2002; 52: 52-3.
19. Dijkman GA, Debrune FMJ. Epidemiology of prostate cancer. Eur Urol 1996; 30: 281.
20. Ahmed Z, Muzaffar S. Prostatic carcinoma with emphasis on Gleason's grading: an institution based experience. J Pak Med Assoc 2002; 52:54-6.
21. Haapiainen RK, Permi EJ, Rannikko SAS, Vontilainen PEJ, Liewendahl K, Stenonan VH, et al. Prostate tumour markers as an aid in the staging of prostatic cancer. Br J Urol 1990; 65: 264-7.
22. Brawer MK, Rennels MA, Nagle RB, Schifman R, Gaines JA. Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy. Am J Clin Path 1989; 92: 760-4.
23. Szymanowski J, Dudek P, Ratajski J, Wyoscocki M. Correlations among prostate-specific antigen, Gleason score, staging and grading in patients after radical prostatectomy. BJU Int 2002; 89: 612-3.
24. Altay B, Kefi A, Nazli O, Killi R, Semerci B, Akbar I. Comparison of Gleason score from sextant prostate biopsies and radical prostatectomy specimens. Urol Int 2001; 67: 14-8.
25. Heller JE. Prostatic acid phosphatases: its current clinical status. J Urol 1987; 137: 1091.